Intra- thecal antitetanus serum in the management of tetanus neonatorum.
Eleven neonates have treated with intra-thecal antitetanus serum in addition to other standard measures. Five survived. The results were judged promising.
D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000628:therapy*; D007278:Injections, Spinal; D013742:Tetanus / Q000628:therapy*; D013743:Tetanus Antitoxin / Q000627:therapeutic use*
D013743:Tetanus Antitoxin